These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8702832)

  • 1. Inhibition of HIV-1 production and selective degradation of viral RNA by an amphibian ribonuclease.
    Saxena SK; Gravell M; Wu YN; Mikulski SM; Shogen K; Ardelt W; Youle RJ
    J Biol Chem; 1996 Aug; 271(34):20783-8. PubMed ID: 8702832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase inhibition of human immunodeficiency virus infection of H9 cells.
    Youle RJ; Wu YN; Mikulski SM; Shogen K; Hamilton RS; Newton D; D'Alessio G; Gravell M
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6012-6. PubMed ID: 8016107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.
    Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ
    J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.
    Newton DL; Boque L; Wlodawer A; Huang CY; Rybak SM
    Biochemistry; 1998 Apr; 37(15):5173-83. PubMed ID: 9548748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis.
    Iordanov MS; Ryabinina OP; Wong J; Dinh TH; Newton DL; Rybak SM; Magun BE
    Cancer Res; 2000 Apr; 60(7):1983-94. PubMed ID: 10766189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression.
    Bedoya VI; Boasso A; Hardy AW; Rybak S; Shearer GM; Rugeles MT
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):897-907. PubMed ID: 16989616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon enhances the activity of the anticancer ribonuclease, onconase.
    Vasandani VM; Castelli JC; Hott JS; Saxena S; Mikulski SM; Youle RJ
    J Interferon Cytokine Res; 1999 May; 19(5):447-54. PubMed ID: 10386856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.
    Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM
    Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
    Domachowske JB; Dyer KD; Adams AG; Leto TL; Rosenberg HF
    Nucleic Acids Res; 1998 Jul; 26(14):3358-63. PubMed ID: 9649619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribotoxin restrictocin manifests anti-HIV-1 activity through its specific ribonuclease activity.
    Yadav SK; Batra JK
    Int J Biol Macromol; 2015 May; 76():58-62. PubMed ID: 25709025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entry into cells and selective degradation of tRNAs by a cytotoxic member of the RNase A family.
    Saxena SK; Sirdeshmukh R; Ardelt W; Mikulski SM; Shogen K; Youle RJ
    J Biol Chem; 2002 Apr; 277(17):15142-6. PubMed ID: 11839736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and analysis of nonpolar regions in onconase.
    Kolbanovskaya EY; Terwisscha van Scheltinga AC; Mukhortov VG; Ardelt W; Beintema JJ; Karpeisky MY
    Cell Mol Life Sci; 2000 Aug; 57(8-9):1306-16. PubMed ID: 11028920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
    J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease.
    Lin JJ; Newton DL; Mikulski SM; Kung HF; Youle RJ; Rybak SM
    Biochem Biophys Res Commun; 1994 Oct; 204(1):156-62. PubMed ID: 7945354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the intracellular routing of cytotoxic ribonucleases.
    Wu Y; Saxena SK; Ardelt W; Gadina M; Mikulski SM; De Lorenzo C; D'Alessio G; Youle RJ
    J Biol Chem; 1995 Jul; 270(29):17476-81. PubMed ID: 7542240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
    Ben-Artzi H; Zeelon E; Gorecki M; Panet A
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities.
    Gerondelis P; Archer RH; Palaniappan C; Reichman RC; Fay PJ; Bambara RA; Demeter LM
    J Virol; 1999 Jul; 73(7):5803-13. PubMed ID: 10364332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onconase action on tRNA(Lys3), the primer for HIV-1 reverse transcription.
    Suhasini AN; Sirdeshmukh R
    Biochem Biophys Res Commun; 2007 Nov; 363(2):304-9. PubMed ID: 17888404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.
    Juan G; Ardelt B; Li X; Mikulski SM; Shogen K; Ardelt W; Mittelman A; Darzynkiewicz Z
    Leukemia; 1998 Aug; 12(8):1241-8. PubMed ID: 9697879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.